Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Whitehead

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Emergency Medical Services|March 5, 2004
Blood on tap. Part 1. History in the makingSteve Whitehead
Journal of Aging and Health|April 7, 2011
Home care clients in the last year of life: is material deprivation associated with service characteristics?Donna Goodridge, Alan Buckley, Josh Marko, et al.
Plos Pathogens|February 27, 2018
Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopesEmily N Gallichotte, Thomas J Baric, Boyd L Yount, et al.
Experimental Biology and Medicine (Maywood, N.J.)|February 3, 2023
The dengue virus 4 component of NIAID's tetravalent TV003 vaccine drives its innate immune signatureJessica Pintado Silva, Rafael Fenutria, Dabeiba Bernal-Rubio, et al.
The Journal of Infectious Diseases|June 29, 2007
Maternal antibody and viral factors in the pathogenesis of dengue virus in infantsCameron P Simmons, Tran Nguyen Bich Chau, Tran Thi Thuy, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Emergency Medical Services|March 5, 2004
Blood on tap. Part 1. History in the makingSteve Whitehead
Journal of Aging and Health|April 7, 2011
Home care clients in the last year of life: is material deprivation associated with service characteristics?Donna Goodridge, Alan Buckley, Josh Marko, et al.
Plos Pathogens|February 27, 2018
Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopesEmily N Gallichotte, Thomas J Baric, Boyd L Yount, et al.
Experimental Biology and Medicine (Maywood, N.J.)|February 3, 2023
The dengue virus 4 component of NIAID's tetravalent TV003 vaccine drives its innate immune signatureJessica Pintado Silva, Rafael Fenutria, Dabeiba Bernal-Rubio, et al.
The Journal of Infectious Diseases|June 29, 2007
Maternal antibody and viral factors in the pathogenesis of dengue virus in infantsCameron P Simmons, Tran Nguyen Bich Chau, Tran Thi Thuy, et al.
Pageof 1